OmniAb (OABI)
Provides antibody-discovery technologies that feed partner drug programs and royalty economics.
$4.82
vs last close−0.10 (−2.07%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 41 days
EPS estimate
−$0.12
Revenue estimate
$3.4M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.12−$0.17−$0.15−$0.14−$0.11−$0.06−$0.05Pending
Estimate−$0.13−$0.17−$0.14−$0.14−$0.08−$0.10−$0.12−$0.12
Surprise+7.7%0.0%−7.1%−2.9%−37.5%+40.0%+58.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$10.8M$4.2M$3.9M$2.2M$8.4M$14.4M$13.4MPending
Estimate$6.5M$4.5M$5.6M$5.6M$9.0M$5.6M$4.7M$3.4M
Surprise+65.3%−7.5%−31.0%−60.3%−7.0%+157.6%+185.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.07 | — | — |
| Sep 2027 | −$0.11 | — | — |
| Jun 2027 | −$0.10 | — | — |
| Mar 2027 | −$0.10 | — | — |
| Dec 2026 | −$0.13 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Aug 2026 | −$0.12 | −$0.05 | +58.3% |
| May 2026 | −$0.10 | −$0.06 | +40.0% |
| Mar 2026 | −$0.08 | −$0.11 | −37.5% |
| Nov 2025 | −$0.14 | −$0.14 | −2.9% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Mar 2022 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.07 | — | — | $12.9M | — | — | — |
| Sep 2027 | −$0.11 | — | — | $7.6M | — | — | — |
| Jun 2027 | −$0.10 | — | — | $7.8M | — | — | — |
| Mar 2027 | −$0.10 | — | — | $7.0M | — | — | — |
| Dec 2026 | −$0.13 | — | — | $3.8M | — | — | — |
| Nov 3, 2026 | −$0.12 | — | — | $3.4M | — | — | — |
| Aug 6, 2026 | −$0.12 | −$0.05 | +58.3% | $4.7M | $13.4M | +185.9% | +37.5% |
| May 7, 2026 | −$0.10 | −$0.06 | +40.0% | $5.6M | $14.4M | +157.6% | +12.9% |
| Mar 4, 2026 | −$0.08 | −$0.11 | −37.5% | $9.0M | $8.4M | −7.0% | +10.5% |
| Nov 4, 2025 | −$0.14 | −$0.14 | −2.9% | $5.6M | $2.2M | −60.3% | −3.4% |
| Aug 6, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 18, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 20, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 12, 2022 | |||||||
| May 20, 2022 | |||||||
| Mar 25, 2022 | |||||||
| Mar 28, 2022 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 |